EUVIMEDEUVIMED entdecken
Crossref

Elucidation of lorlatinib toxicity mechanisms through GC-MS-based metabolomics

Di Niu, Shiyuan Zhao, Shanshan Kong, Xue Zhang, Chunyan Ma

Journal of Pharmaceutical and Biomedical Analysis · 2025-11 · 265 · 117017

DOI: 10.1016/j.jpba.2025.117017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2025-11. Verfasst von Di Niu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: niudi3703@163…. Hauptthemen laut MEDLINE: Metabolomics, Lactams, Lactams, Macrocyclic, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, The Natural Science Foundation of Shandong Province, Key R&D Program of Jining.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor that demonstrates superior efficacy in the treatment of non-small cell lung cancer (NSCLC). However, its toxicological profile remains insufficiently understood. In this study, we employed an untargeted metabolomics approach. Differential metabolites were identified in the hippocampus, cerebral cortex, lungs, and serum between the control and lorlatinib-treated groups of mice. Subsequently, KEGG pathway enrichment analysis was performed on these differential metabolites. The findings suggest that lorlatinib may exert toxicity by disrupting lipid metabolism, linoleic acid metabolism, niacin and nicotinamide metabolism, as well as the synthesis and metabolic pathways of multiple amino acids. This study clarifies the impact of lorlatinib exposure on metabolic profiles across various mouse tissues, identifies metabolism-related pathways linked to lorlatinib toxicity, and provides new insights into its toxicological mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsLactamsLactams, MacrocyclicProtein Kinase InhibitorsAntineoplastic AgentsAnimalsMiceGas Chromatography-Mass SpectrometryAminopyridinesMaleLipid MetabolismMetabolic Networks and PathwaysAnaplastic Lymphoma KinaseCarcinoma, Non-Small-Cell LungLungMice, Inbred C57BLPyrazoles

Stichwörter der Autor:innen

Differential metabolitesGC-MSLorlatinibMetabolomeMouse modelToxicity

Substanzen

lorlatinibLactamsLactams, MacrocyclicAminopyridinesProtein Kinase InhibitorsAnaplastic Lymphoma KinaseAntineoplastic AgentsPyrazoles

Autor:innen und Institutionen

  • Department of Neurosurgery, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: niudi3703@163.com.
  • Translational Pharmaceutical Laboratory, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: zhaoshiyuan94@163.com.
  • Department of Clinical Pharmacy, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: ksspharm@163.com.
  • Department of Clinical Pharmacy, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: 2277937062@qq.com.
  • Department of Clinical Pharmacy, Jining No.1 People's Hospital, Shandong First Medical University, Jining 272000, China. Electronic address: 848941385@qq.com.

Förderung

  • Natural Science Foundation of Shandong Province
  • The Natural Science Foundation of Shandong Province
  • Key R&D Program of Jining

Zitieren

APA

Niu, D., Zhao, S., Kong, S., Zhang, X., & Ma, C. (2025). Elucidation of lorlatinib toxicity mechanisms through GC-MS-based metabolomics. Journal of Pharmaceutical and Biomedical Analysis, 265, 117017. https://doi.org/10.1016/j.jpba.2025.117017

Vancouver

Niu D, Zhao S, Kong S, Zhang X, Ma C. Elucidation of lorlatinib toxicity mechanisms through GC-MS-based metabolomics. Journal of Pharmaceutical and Biomedical Analysis. 2025;265:117017. doi:10.1016/j.jpba.2025.117017

BibTeX
@article{Niu2025,
  author = {Niu, Di and Zhao, Shiyuan and Kong, Shanshan and Zhang, Xue and Ma, Chunyan},
  title = {Elucidation of lorlatinib toxicity mechanisms through GC-MS-based metabolomics},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2025},
  volume = {265},
  pages = {117017},
  doi = {10.1016/j.jpba.2025.117017}
}
Kostenlos starten →